Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingli Dong

Showing results (31-40 of 198) with videos related to

Pageof 20
Sort By:
Modern Rheumatology|July 5, 2022
Prevalence and risk factors of monoclonal gammopathy in patients with autoimmune inflammatory rheumatic disease: A systematic review and meta-analysisZhiqian Bai, Chuanyu Hu, Jixin Zhong, et al.
Seminars in Arthritis and Rheumatism|July 8, 2022
Immunopathogenesis of Sjogren's syndrome: Current state of DAMPsBingxia Ming, Yaowu Zhu, Jixin Zhong, et al.
Rheumatology (Oxford, England)|February 15, 2023
Regulatory T cells: a new therapeutic link for Sjögren syndrome?Bingxia Ming, Yaowu Zhu, Jixin Zhong, et al.
American Journal of Hematology|July 29, 2008
Evolution of ADAMTS13 antibodies in a fatal case of thrombotic thrombocytopenic purpuraLingli Dong, Visalam Chandrasekaran, Wenhua Zhou, et al.
Arthritis Research & Therapy|January 10, 2025
Eltrombopag for the treatment of refractory connective tissue disease-related thrombocytopenia: a pilot study of 52 casesSiying Deng, Bei Wang, Ziwei Hu, et al.
Seminars in Arthritis and Rheumatism|May 20, 2020
Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei, ChinaYu Chen, Yuanji Dong, Shaozhe Cai, et al.
Colloids and Surfaces. B, Biointerfaces|July 2, 2017
Amphipathic dextran-doxorubicin prodrug micelles for solid tumor therapyRong Jin, Xuelian Guo, Lingli Dong, et al.
Clinical Immunology (Orlando, Fla.)|February 18, 2026
Decorin as a dynamic regulator in fibrosis: Mechanisms, therapeutic potential and future challengesWenqian Zhang, Shaozhe Cai, Jiayi Ma, et al.
International Immunopharmacology|March 31, 2019
α-Difluoromethylornithine suppresses inflammatory arthritis by impairing myeloid-derived suppressor cellsZhe Geng, Bingxia Ming, Shaoxian Hu, et al.
Rheumatology and Immunology Research|June 30, 2022
Recommendations on SARS-CoV-2 vaccination in adult patients with rheumatic diseasesMin Shen, Lingli Dong, Mengtao Li, et al.
Pageof 20

Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Modern Rheumatology|July 5, 2022
Prevalence and risk factors of monoclonal gammopathy in patients with autoimmune inflammatory rheumatic disease: A systematic review and meta-analysisZhiqian Bai, Chuanyu Hu, Jixin Zhong, et al.
Seminars in Arthritis and Rheumatism|July 8, 2022
Immunopathogenesis of Sjogren's syndrome: Current state of DAMPsBingxia Ming, Yaowu Zhu, Jixin Zhong, et al.
Rheumatology (Oxford, England)|February 15, 2023
Regulatory T cells: a new therapeutic link for Sjögren syndrome?Bingxia Ming, Yaowu Zhu, Jixin Zhong, et al.
American Journal of Hematology|July 29, 2008
Evolution of ADAMTS13 antibodies in a fatal case of thrombotic thrombocytopenic purpuraLingli Dong, Visalam Chandrasekaran, Wenhua Zhou, et al.
Arthritis Research & Therapy|January 10, 2025
Eltrombopag for the treatment of refractory connective tissue disease-related thrombocytopenia: a pilot study of 52 casesSiying Deng, Bei Wang, Ziwei Hu, et al.
Seminars in Arthritis and Rheumatism|May 20, 2020
Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei, ChinaYu Chen, Yuanji Dong, Shaozhe Cai, et al.
Colloids and Surfaces. B, Biointerfaces|July 2, 2017
Amphipathic dextran-doxorubicin prodrug micelles for solid tumor therapyRong Jin, Xuelian Guo, Lingli Dong, et al.
Clinical Immunology (Orlando, Fla.)|February 18, 2026
Decorin as a dynamic regulator in fibrosis: Mechanisms, therapeutic potential and future challengesWenqian Zhang, Shaozhe Cai, Jiayi Ma, et al.
International Immunopharmacology|March 31, 2019
α-Difluoromethylornithine suppresses inflammatory arthritis by impairing myeloid-derived suppressor cellsZhe Geng, Bingxia Ming, Shaoxian Hu, et al.
Rheumatology and Immunology Research|June 30, 2022
Recommendations on SARS-CoV-2 vaccination in adult patients with rheumatic diseasesMin Shen, Lingli Dong, Mengtao Li, et al.
Pageof 20